aura biosciences

Aura Biosciences nabs $4 million for its pseudovirion-based targeted cancer therapy

A hot segment of targeted cancer therapy is using synthetic viruses, or pseudovirions, to serve as mini drug delivery capsules. These tiny protein shells are engineered to hone in to attack certain cancerous cells – avoiding healthy tissue completely. This model of treatment prevents the toxic cancers from affecting the non-cancerous parts of the body. Cambridge-based pseudovirion developer Aura […]